Hysterectomy and Cardiometabolic Risk: A Comprehensive Review

N. Jayasree*; K. Ruchitha; Vijayalakshmi Cholavaram; O. Susmitha; Sk. Davood

Department of Pharmacy Practice, Swathi College of Pharmacy, Nellore, Andhra Pradesh

*Correspondence: nandipallijayasree3814@gmail.com ;

DOI: https://doi.org/10.71431/IJRPAS.2025.41006

 INTRODUCTION

Hysterectomy, the surgical removal of the uterus, is one of the most frequently performed gynaecological procedures worldwide, particularly among women in their midlife. While it is often indicated for benign conditions such as uterine fibroids, abnormal uterine bleeding, adenomyosis, or pelvic pain, as well as for malignant diseases, its long-term health consequences have been increasingly recognized in recent decades. Beyond its reproductive implications, hysterectomy—especially when performed at a younger age and/or with concomitant oophorectomy—has been associated with metabolic and cardiovascular disturbances that can significantly affect women’s health outcomes later in life[1].

A growing body of evidence suggests that hysterectomy may contribute to the development of metabolic disorders such as type 2 diabetes mellitus (T2DM) and cardiovascular risk factors such as hypertension. The underlying mechanisms are thought to be multifactorial. Removal of the uterus, particularly when accompanied by bilateral oophorectomy, can disrupt the hypothalamic–pituitary–ovarian axis, leading to alterations in sex hormone levels, early menopause, and reduced estrogen protection. Estrogen deficiency has been linked to insulin resistance, visceral fat accumulation, dyslipidemia, endothelial dysfunction, and increased sympathetic activity, all of which predispose women to diabetes and hypertension. Even in women undergoing hysterectomy with ovarian conservation, changes in ovarian blood supply and function may accelerate hormonal decline, thereby influencing metabolic pathways[2].

Several epidemiological studies have reported higher prevalence rates of hypertension and diabetes among women with a history of hysterectomy compared to age-matched controls. These risks appear to be more pronounced in women who undergo hysterectomy at a younger age (<40 years), suggesting that early loss of reproductive organs may amplify long-term metabolic consequences. Additionally, lifestyle factors, genetic predispositions, and pre-existing gynecological conditions may further contribute to the observed associations.

Given the increasing rates of hysterectomy, particularly in countries like India where it is sometimes performed at a relatively young age, understanding its potential role in the development of diabetes mellitus and hypertension has significant public health importance. This warrants comprehensive evaluation, as it not only impacts the immediate postoperative outcomes but also has profound implications for women’s long-term quality of life, morbidity, and mortality.                              

Hysterectomy: Hormonal and Metabolic Effects:

A hysterectomy, which involves removing the uterus, can influence hormones and metabolism in different ways depending on whether the ovaries are kept or removed.

Hormonal Effects:

1. Uterus removed but ovaries retained (without oophorectomy):

The ovaries still make oestrogen, progesterone, and androgens, though blood circulation to them may be slightly reduced after surgery.

Because of this, menopause may occur a few years earlier than usual (often 3–5 years).

Even with ovarian function, some individuals notice menopausal-like symptoms such as hot flashes or mood fluctuations.

2. Uterus and ovaries removed (with bilateral oophorectomy):

Hormone production from the ovaries stops suddenly, resulting in surgical menopause.

Symptoms appear abruptly and are often stronger, including night sweats, hot flashes, vaginal dryness, reduced sexual desire, mood instability, and sleep problems[3].

Metabolic Effects:

The drop in estragon in particular has widespread metabolic consequences:

1. Bone Health – Oestrogen normally helps preserve bone density; its absence accelerates bone thinning, raising osteoporosis and fracture risk.

2. Cardiovascular Function – Lower oestrogen levels increase the chances of high blood pressure, abnormal cholesterol (↑ LDL, ↓ HDL), and artery hardening.

3. Body Composition – Fat tends to collect in the abdominal area, while muscle mass may decline.

4. Glucose Control – Some people develop reduced insulin sensitivity, making metabolic syndrome and type 2 diabetes more likely.

5. Other Hormonal Interactions – The brain’s hormone-control center (hypothalamic-pituitary axis) adapts to the loss, occasionally affecting thyroid and adrenal balance in minor ways.

Management

Hormone Replacement Therapy (HRT): Often prescribed after ovary removal (if safe) to ease symptoms and lower risks like osteoporosis or heart disease.

Lifestyle: Weight-bearing exercise, a diet rich in calcium and vitamin D, and cardiovascular-friendly habits help reduce complications.

Monitoring: Regular bone density checks, lipid testing, and metabolic follow-up are recommended[4].

Hysterectomy in Patients with Hypertension:

1.Preoperative Care:

Blood pressure optimization: Good control of hypertension is essential before surgery, as uncontrolled values increase anaesthesia and surgical risks. For elective cases, blood pressure should ideally be stabilized below 140/90 mmHg.

Cardiovascular risks: Patients with untreated or poorly managed hypertension are more prone to complications such as stroke, heart attack, irregular rhythms, and excessive intra operative bleeding[5].

Medication plan: Most anti-hypertensive drugs—including ACE inhibitors, ARBs, calcium channel blockers, and beta-blockers—should be continued up to and including the day of surgery. However, diuretics are often withheld on the morning of the operation to avoid electrolyte imbalance and dehydration.

Pre-operative investigations: Baseline tests may include ECG, kidney function, and electrolyte levels. If the patient has had long-standing hypertension, an echo-cardiogram may be warranted to assess cardiac status.

2. Intraoperative Care:

Monitoring: Continuous and careful tracking of hemodynamic by the anaesthesia team is vital.

Hypertensive episodes: Sudden rises in blood pressure can occur during induction, intubation, or surgical stress; these are controlled with intravenous antihypertensives.

Hypotension risk: Patients with chronic hypertension may react unpredictably to blood loss, sometimes experiencing exaggerated drops in pressure.

3. Postoperative Care:

Blood pressure stability: Pain, surgical stress, or delayed antihypertensive dosing may trigger BP spikes.

Medication resumption: Oral antihypertensives should be restarted as soon as the patient is able to take fluids orally.

Complication watch: Vigilance is required for hypertensive crises, arrhythmias, or excessive bleeding in the recovery period.

4. Surgical Options:

Approach selection: Abdominal, vaginal, or laparoscopic hysterectomy can all be performed safely if hypertension is well controlled.

Preference: Minimally invasive techniques (laparoscopic or vaginal routes) are usually favoured because they reduce recovery time and impose less strain on the cardiovascular system compared to open abdominal surgery.

Hysterectomy in Patients with Diabetes Mellitus:

1. Preoperative Care:

Glycaemic optimization: Diabetes should be well managed before surgery, since uncontrolled blood sugar raises the chances of infection, poor wound repair, cardiovascular issues, and slower recovery.

Targets: For elective cases, fasting glucose should generally be kept below 140 mg/dL, and HbA1c ideally maintained around 7–8%.

Medication adjustment:

Oral agents (like metformin or sulfonylureas) may need to be stopped or adjusted on the morning of surgery.

Insulin doses are often modified—for example, lowering long-acting insulin or using IV insulin infusion during the operation.

Pre-op investigations: Routine checks include blood glucose profile, HbA1c, kidney function, electrolytes, and ECG, given the higher cardiac risk in diabetics.

2. Intraoperative care:

Glucose monitoring: Blood sugar should be assessed frequently throughout the procedure.

Control measures: An insulin–glucose–potassium infusion is sometimes used to stabilize glucose between 140–180 mg/dL.

Aesthetic vigilance: Hypoglycaemia can be masked under anaesthesia, while hyperglycaemia must also be corrected promptly.

3. Postoperative Care:

Resuming therapy: Oral hypoglycaemics or insulin should be restarted as soon as the patient can tolerate food.

Monitoring: For patients on insulin, glucose checks every 4–6 hours are recommended.

Complication watch: Diabetic patients are more prone to wound and urinary infections, pneumonia, and delayed healing.

Recovery support: Good pain relief and early mobilization help reduce postoperative risk

4. Surgical Approach:

Preferred routes: Vaginal and laparoscopic hysterectomy are generally safer, as they involve smaller incisions, lower infection risk, and faster recovery.

Abdominal route: May still be required in certain situations but carries a greater likelihood of wound-related problems in diabetic individuals[6].

Clinical Implications:

women with a history of hysterectomy show a higher risk of developing hypertension, especially if surgery occurs at a younger age or involves oophorectomy.

Hypertension increases the risk of cardiovascular disease, renal complications, and long-term morbidity in these patients.

Regular blood pressure monitoring and early intervention are essential after hysterectomy.

Lifestyle counselling (diet, exercise, weight control) and, if needed, antihypertensive therapy should be integrated into postoperative care[7].

Clinicians should adopt a multidisciplinary approach involving gynaecologists, cardiologists, and primary care providers.

Public Health Implications:

Rising hysterectomy rates, particularly in low- and middle-income countries, may contribute to a greater burden of hypertension and cardiovascular disease in women.

Public health programs should emphasize awareness of cardiovascular risks associated with hysterectomy.

Screening policies for hypertension should include women with prior hysterectomy as a high-risk group.

Preventive strategies, including education on non-surgical alternatives for benign gynaecological conditions, could reduce long-term complications.

Longitudinal population-based studies are needed to guide policies on hysterectomy practices and post-surgical follow-up[8].

FUTURE RESEARCH DIRECTIONS:

1. Longitudinal Cohort Studies:

Large, prospective, multi-ethnic cohorts are needed to confirm the causal relationship between hysterectomy and the development of hypertension across different age groups and surgical types (with/without oophorectomy).

2. Mechanistic Studies:

Investigate biological mechanisms, including hormonal alterations, vascular endothelial dysfunction, sympathetic nervous system activity, and renin–angiotensin–aldosterone system changes after hysterectomy.

3. Role of Ovarian Preservation:

Compare cardiovascular and blood pressure outcomes between women undergoing hysterectomy with ovarian preservation versus bilateral oophorectomy to identify differential risks[9].

4. Timing of Surgery and Age:

Assess how age at hysterectomy influences long-term hypertension risk, especially in women undergoing surgery before natural menopause.

5. Interaction with Other Risk Factors:

Explore the interaction between hysterectomy and obesity, diabetes, dyslipidaemia, and genetic predisposition in contributing to hypertension.

6. Lifestyle and Preventive Interventions:

Evaluate whether lifestyle modification (diet, exercise, weight control) or preventive pharmacotherapy post-hysterectomy can mitigate the increased risk of hypertension.

7. Health Disparities Research:

Examine socio-economic, geographic, and racial/ethnic differences in hysterectomy prevalence and associated hypertension outcomes to address health inequities.

8. Quality of Life and Long-term Outcomes:

Study how hysterectomy-related hypertension affects quality of life, healthcare costs, and long-term cardiovascular morbidity and mortality.

9. Molecular and Genetic Markers:

Identify biomarkers (hormonal, inflammatory, or genetic) that may predict which women are most vulnerable to developing hypertension after hysterectomy.

10. Interventional Trials:

Randomized controlled trials assessing early screening, anti-hypertensive therapy initiation, or hormone replacement therapy (HRT) use post-hysterectomy to determine effective prevention strategies.

PRECAUTIONS:

Hysterectomy, although often necessary for benign and malignant gynecological conditions, has been increasingly associated with long-term metabolic and cardiovascular complications. These include increased incidence of type 2 diabetes mellitus (T2DM) and hypertension, particularly among women undergoing hysterectomy at a younger age or with concomitant bilateral oophorectomy. Thus, careful precautionary strategies must be adopted at different stages of patient care[10].

1. Pre-operative Precautions:

a. Patient Selection and Surgical Indication Strict indication criteria:

 Hysterectomy should not be the first-line intervention for benign conditions such as fibroids, adenomyosis, or heavy menstrual bleeding unless conservative options (hormonal therapy, endometrial ablation, myomectomy, uterine artery embolization) have been exhausted.

Age considerations: Women <40 years should undergo hysterectomy only when strongly indicated, as younger age increases long-term risk of diabetes and hypertension due to premature decline in ovarian hormones[11-13].

b. Baseline Clinical Assessment Cardiometabolic screening:

Measure blood pressure, fasting blood glucose, HbA1c, and lipid profile prior to surgery. Evaluate body mass index (BMI), waist–hip ratio, and family history of diabetes or hypertension.

Risk stratification: Identify patients at high risk (obese women, those with pre-diabetes, polycystic ovary syndrome, or metabolic syndrome) for closer follow-up[14].

c. Patient Counselling:

Inform women about potential long-term risks of hysterectomy, particularly metabolic disorders.

Discuss ovarian conservation: Preserving ovaries (when clinically appropriate) helps maintain estrogen production, delaying metabolic and cardiovascular complications.

Shared decision-making: Patients should be made active participants in surgical decisions, balancing risks, benefits, and long-term health outcomes[15].

2. Peri-operative Precautions:

a. Surgical Technique Ovarian preservation:

Unless malignancy or severe ovarian disease is present, bilateral oophorectomy should be avoided.

Even with ovarian conservation, surgeons must take care to maintain ovarian blood supply to prevent accelerateds ovarian failure.

Minimally invasive approaches: Laparoscopic or vaginal hysterectomy, when possible, should be preferred over abdominal hysterectomy to reduce surgical trauma and stress response[16-18].

b. Stress Response Management:

Anesthetic precautions: Proper anaesthesia techniques should be used to reduce perioperative stress-induced hyperglycaemia and hypertension.

Hemodynamic monitoring: Continuous monitoring of blood pressure and glucose levels during surgery can help prevent acute metabolic disturbances.

c. Immediate Post-operative Care:

Pain and stress control: Adequate analgesia lowers sympathetic activation, reducing the risk of perioperative hypertension and hyperglycaemia.

Early mobilization: Encourages better circulation, metabolic activity, and faster recovery[19].

3. Post-operative and Long-term Precautions:

a. Clinical Monitoring:

Regular follow-up: Women should undergo periodic monitoring of:

Blood pressure (at least annually or earlier if abnormal).

Blood sugar (fasting glucose, oral glucose tolerance test, HbA1c).

Lipid profile and weight/BMI.

Early detection: Women who had hysterectomy at a younger age should begin metabolic screening earlier than the general population[20].

b. Hormonal Considerations:

Estrogen deficiency: After hysterectomy with oophorectomy or premature ovarian failure, estrogen levels decline rapidly.

Hormone replacement therapy (HRT): May be considered in eligible women to alleviate estrogen deficiency and lower risks of insulin resistance, vascular stiffness, and endothelial dysfunction. HRT decisions should be individualized based on age, menopausal status, and contraindications.

c. Lifestyle Modifications

Dietary precautions:

Encourage a heart-healthy diet (rich in vegetables, fruits, whole grains, lean protein, and omega-3 fatty acids).

Restrict refined sugars, trans fats, and high-sodium foods to reduce risk of diabetes and hypertension[21].

Physical activity:

At least 150 minutes of moderate aerobic exercise per week (e.g., brisk walking, swimming, cycling).

Incorporate strength training for muscle mass maintenance, which improves insulin sensitivity.

Weight management: Maintain a healthy BMI to prevent central obesity, which is strongly linked with diabetes and hypertension.

Lifestyle risk avoidance: Abstain from smoking and limit alcohol, as both amplify cardiovascular and metabolic risks[22].

d. Psychosocial and Emotional Well-being:

Post-surgical anxiety and depression can increase stress hormones (cortisol, catecholamines), which worsen metabolic control.

Psychological counselling, support groups, and stress-reduction techniques (yoga, meditation) can reduce long-term risks indirectly[23].

4. Public Health and Preventive Strategies:

Awareness programs: Educate women—particularly in regions with high hysterectomy rates (e.g., rural India)—about long-term health risks.

Healthcare provider training: Gynaecologists, endocrinologists, and primary care physicians should coordinate follow-up care.

Early intervention: Women with hysterectomy should be included in targeted screening programs for diabetes and hypertension[24].

 CONCLUSION: 

Hysterectomy, one of the most common gynaecological surgeries, has implications beyond reproductive health and may contribute to an elevated risk of hypertension. Evidence from observational and cohort studies indicates that women with hysterectomy show a 20-30% higher incidence of hypertension compared to age matched controls, with the risk being more pronounced in those who underwent surgery before age 40 or had concurrent bilateral oophorectomy[25-26]. Estrogen deficiency, impaired ovarian blood supply, and accelerated vascular aging are key mechanisms proposed. In addition, comorbid conditions such as obesity, diabetes, metabolic syndrome, and pre-existing gynaecological disorders further amplify the risk. While the absolute increase in hypertension prevalence is modest, the high global rates of hysterectomy make this a significant public health concern. Therefore, routine cardiovascular risk assessment, lifestyle counselling, and long-term follow-up should be integrated into the post-hysterectomy care plan. Further prospective, large-scale studies are needed to establish causality and guide preventive strategies tailored to individual risk profiles[27-28].

REFERENCES:

1.    Mikhail E., Salemi J., Mogos M., Hart S., Salihu H., Imudia A. National trends of adnexal surgery at the time of hysterectomy for benign indication, United States 1998-2011. J. Minim. Invasive Gynecol. 2015 Mar 1;22(3):S18. doi: 10.1016/j.ajog.2015.04.031

2.    Matthews KA, Gibson CJ, El Khoudary SR, et al. Changes in cardiovascular risk factors by hysterectomy status with and without oophorectomy: study of women’s health across the nation. J Am Coll Cardiol 2013;62:191–200. doi:10.1016/j.jacc.2013.04.042FREE Full Text Google Scholar

3.    James SL, Abate D, Abate KH. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the global burden of disease study 2017. Lancet 2018;392:1789–858. doi:10.1016/S0140-6736(18)32279-7CrossRefPubMedGoogle Scholar

4.    Mosca, L. ∙ Benjamin, E.J. ∙ Berra, K. ... Effectiveness-Based Guidelines for the Prevention of Cardiovascular Disease in Women—2011 Update Circulation. 2011; 123:1243-1262 Crossref Scopus (1378) PubMed Google Scholar

5.    R. Venturella et al.3 to 5 Years later: long-term effects of prophylactic bilateral salpingectomy on ovarian function B.G. Kim et al. Relation of preprocedural haemoglobin level to outcomes after percutaneous coronary intervention

6.    Aarts JWM, Nieboer TE, Johnson N, et al. Surgical approach to hysterectomy for benign gynaecological disease. Cochrane Database Syst Rev 2015;2015:CD003677. doi: 10.1002/14651858.CD003677.pub5Google Scholar

7.    International Institute for Population Sciences (IIPS) and ICF. (2021). National Family Health Survey (NFHS-5), 2019–21: India. Mumbai, India. Available at:

8.    Bhaumik, S. (2013). Oxfam calls for new regulations to reduce unnecessary hysterectomies in private hospitals. BMJ, 346, f852.

9.    Mills, K. T., Stefanescu, A., & He, J. (2020). The global epidemiology of hypertension. Nature Reviews Nephrology, 16, 223–237.

10.    Zhou, B., Carrillo-Larco, R. M., Danaei, G., et al. (2021). Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: A pooled analysis of 1201 population-representative studies with 104 million participants. The Lancet, 398, 957–980.

11.    James, S. L., Abate, D., Abate, K. H., et al. (2018). Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: A systematic analysis for the Global Burden of Disease Study 2017. The Lancet, 392, 1789–1858.

12.    Ding, D.-C., & Sung, F.-C. (2018). Authors’ reply re: Risk of hypertension after hysterectomy: A population-based study. BJOG, 125, 1780.

13.    Laughlin-Tommaso, S. K., Khan, Z., Weaver, A. L., et al. (2018). Cardiovascular and metabolic morbidity after hysterectomy with ovarian conservation: A cohort study. Menopause, 25, 483–492.

14.    Halli, S. S., Singh, D. P., & Biradar, R. A. (2020). Increased hypertension following hysterectomy among reproductive women in India. American Journal of Preventive Cardiology, 4, 100131.

15.    Madika, A.-L., MacDonald, C. J., Gelot, A., et al. (2021). Hysterectomy, non-malignant gynaecological diseases, and the risk of incident hypertension: The E3N prospective cohort. Maturitas, 150, 22–29. https://doi.org/10.1016/j.maturitas.2021.06.001

16.    International Institute for Population Sciences (IIPS). (2020). Longitudinal Ageing Study in India (LASI), Wave 1, 2017–18: India Report. Mumbai, India. Available at:

17.    Perianayagam, A., Bloom, D., Lee, J., et al. (2022). Cohort profile: The longitudinal ageing study in India (LASI). International Journal of Epidemiology, 51, e167–e176.

18.    Hammer, G. P., du Prel, J.-B., & Blettner, M. (2009). Avoiding bias in observational studies: Part 8 in a series of articles on evaluation of scientific publications. Deutsches Ärzteblatt International, 106, 664–668.

19.    Hainmueller, J. (2012). Entropy balancing for causal effects: A multivariate reweighting method to produce balanced samples in observational studies. Political Analysis, 20, 25–46.

20.    Hainmueller, J., & Xu, Y. (2013). Ebalance: A Stata package for entropy balancing. Journal of Statistical Software, 54, 1–18.

21.    Luoto, R., Kaprio, J., Reunanen, A., et al. (1995). Cardiovascular morbidity in relation to ovarian function after hysterectomy. Obstetrics & Gynecology, 85, 515–522.

22.    Laughlin-Tommaso, S. K., Khan, Z., Weaver, A. L., et al. (2016). Cardiovascular risk sfactors and diseases in women undergoing hysterectomy with ovarian conservation. Menopause, 23, 121–128.

23.    Mikhail, E., Miladinovic, B., Velanovich, V., et al. (2015). Association between obesity and the trends of routes of hysterectomy performed for benign indications. Obstetrics & Gynaecology, 125, 912–918.

24.    Hossain, F. B., Adhikary, G., Chowdhury, A. B., et al. (2019). Association between body mass index (BMI) and hypertension in South Asian population: Evidence from nationally-representative surveys. Clinical Hypertension, 25, 28.

25.    Dubey, R. K., Oparil, S., Imthurn, B., et al. (2002). Sex hormones and hypertension. Cardiovascular Research, 53, 688–708.

26.    Lizcano, F., & Guzmán, G. (2014). Estrogen deficiency and the origin of obesity during menopause. BioMed Research International, 2014, 757461.

27.    Maas, A. H. E. M., & Franke, H. R. (2009). Women’s health in menopause with a focus on hypertension. Netherlands Heart Journal, 17, 68–72.

28.    Reckelhoff, J. F., & Fortepiani, L. A. (2004). Novel mechanisms responsible for postmenopausal hypertension. Hypertension, 43, 918–923.